Journal of Controlled Release, volume 161, issue 2, pages 505-522

PLGA-based nanoparticles: An overview of biomedical applications

Publication typeJournal Article
Publication date2012-07-01
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor10.8
ISSN01683659, 18734995
Pharmaceutical Science
Abstract
Poly(lactic-co-glycolic acid) (PLGA) is one of the most successfully developed biodegradable polymers. Among the different polymers developed to formulate polymeric nanoparticles, PLGA has attracted considerable attention due to its attractive properties: (i) biodegradability and biocompatibility, (ii) FDA and European Medicine Agency approval in drug delivery systems for parenteral administration, (iii) well described formulations and methods of production adapted to various types of drugs e.g. hydrophilic or hydrophobic small molecules or macromolecules, (iv) protection of drug from degradation, (v) possibility of sustained release, (vi) possibility to modify surface properties to provide stealthness and/or better interaction with biological materials and (vii) possibility to target nanoparticles to specific organs or cells. This review presents why PLGA has been chosen to design nanoparticles as drug delivery systems in various biomedical applications such as vaccination, cancer, inflammation and other diseases. This review focuses on the understanding of specific characteristics exploited by PLGA-based nanoparticles to target a specific organ or tissue or specific cells.

Citations by journals

10
20
30
40
50
60
70
80
90
International Journal of Pharmaceutics
International Journal of Pharmaceutics, 87, 3.56%
International Journal of Pharmaceutics
87 publications, 3.56%
Journal of Controlled Release
Journal of Controlled Release, 76, 3.11%
Journal of Controlled Release
76 publications, 3.11%
Pharmaceutics
Pharmaceutics, 58, 2.38%
Pharmaceutics
58 publications, 2.38%
Journal of Drug Delivery Science and Technology
Journal of Drug Delivery Science and Technology, 49, 2.01%
Journal of Drug Delivery Science and Technology
49 publications, 2.01%
Colloids and Surfaces B: Biointerfaces
Colloids and Surfaces B: Biointerfaces, 35, 1.43%
Colloids and Surfaces B: Biointerfaces
35 publications, 1.43%
Acta Biomaterialia
Acta Biomaterialia, 32, 1.31%
Acta Biomaterialia
32 publications, 1.31%
Scientific Reports
Scientific Reports, 30, 1.23%
Scientific Reports
30 publications, 1.23%
Journal of Materials Chemistry B
Journal of Materials Chemistry B, 30, 1.23%
Journal of Materials Chemistry B
30 publications, 1.23%
European Journal of Pharmaceutics and Biopharmaceutics
European Journal of Pharmaceutics and Biopharmaceutics, 29, 1.19%
European Journal of Pharmaceutics and Biopharmaceutics
29 publications, 1.19%
International Journal of Biological Macromolecules
International Journal of Biological Macromolecules, 28, 1.15%
International Journal of Biological Macromolecules
28 publications, 1.15%
RSC Advances
RSC Advances, 28, 1.15%
RSC Advances
28 publications, 1.15%
Nanomedicine
Nanomedicine, 27, 1.11%
Nanomedicine
27 publications, 1.11%
Biomacromolecules
Biomacromolecules, 27, 1.11%
Biomacromolecules
27 publications, 1.11%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 26, 1.06%
International Journal of Molecular Sciences
26 publications, 1.06%
Materials Science and Engineering C
Materials Science and Engineering C, 26, 1.06%
Materials Science and Engineering C
26 publications, 1.06%
ACS applied materials & interfaces
ACS applied materials & interfaces, 26, 1.06%
ACS applied materials & interfaces
26 publications, 1.06%
Molecular Pharmaceutics
Molecular Pharmaceutics, 25, 1.02%
Molecular Pharmaceutics
25 publications, 1.02%
Polymers
Polymers, 24, 0.98%
Polymers
24 publications, 0.98%
Advanced healthcare materials
Advanced healthcare materials, 24, 0.98%
Advanced healthcare materials
24 publications, 0.98%
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology, 23, 0.94%
Frontiers in Bioengineering and Biotechnology
23 publications, 0.94%
Advanced Drug Delivery Reviews
Advanced Drug Delivery Reviews, 23, 0.94%
Advanced Drug Delivery Reviews
23 publications, 0.94%
European Journal of Pharmaceutical Sciences
European Journal of Pharmaceutical Sciences, 23, 0.94%
European Journal of Pharmaceutical Sciences
23 publications, 0.94%
Journal of Nanobiotechnology
Journal of Nanobiotechnology, 22, 0.9%
Journal of Nanobiotechnology
22 publications, 0.9%
International Journal of Nanomedicine
International Journal of Nanomedicine, 22, 0.9%
International Journal of Nanomedicine
22 publications, 0.9%
Biomaterials
Biomaterials, 22, 0.9%
Biomaterials
22 publications, 0.9%
Molecules
Molecules, 21, 0.86%
Molecules
21 publications, 0.86%
Nanomaterials
Nanomaterials, 20, 0.82%
Nanomaterials
20 publications, 0.82%
Drug Delivery
Drug Delivery, 20, 0.82%
Drug Delivery
20 publications, 0.82%
PLoS ONE
PLoS ONE, 18, 0.74%
PLoS ONE
18 publications, 0.74%
10
20
30
40
50
60
70
80
90

Citations by publishers

100
200
300
400
500
600
700
800
Elsevier
Elsevier, 718, 29.4%
Elsevier
718 publications, 29.4%
Springer Nature
Springer Nature, 242, 9.91%
Springer Nature
242 publications, 9.91%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 236, 9.66%
Multidisciplinary Digital Publishing Institute (MDPI)
236 publications, 9.66%
Wiley
Wiley, 185, 7.58%
Wiley
185 publications, 7.58%
American Chemical Society (ACS)
American Chemical Society (ACS), 160, 6.55%
American Chemical Society (ACS)
160 publications, 6.55%
Taylor & Francis
Taylor & Francis, 128, 5.24%
Taylor & Francis
128 publications, 5.24%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 122, 5%
Royal Society of Chemistry (RSC)
122 publications, 5%
Frontiers Media S.A.
Frontiers Media S.A., 75, 3.07%
Frontiers Media S.A.
75 publications, 3.07%
Future Medicine
Future Medicine, 45, 1.84%
Future Medicine
45 publications, 1.84%
Hindawi Limited
Hindawi Limited, 32, 1.31%
Hindawi Limited
32 publications, 1.31%
Bentham Science
Bentham Science, 27, 1.11%
Bentham Science
27 publications, 1.11%
Dove Medical Press
Dove Medical Press, 24, 0.98%
Dove Medical Press
24 publications, 0.98%
IOP Publishing
IOP Publishing, 24, 0.98%
IOP Publishing
24 publications, 0.98%
SAGE
SAGE, 20, 0.82%
SAGE
20 publications, 0.82%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 18, 0.74%
Public Library of Science (PLoS)
18 publications, 0.74%
Wolters Kluwer Health
Wolters Kluwer Health, 13, 0.53%
Wolters Kluwer Health
13 publications, 0.53%
Mary Ann Liebert
Mary Ann Liebert, 11, 0.45%
Mary Ann Liebert
11 publications, 0.45%
Pleiades Publishing
Pleiades Publishing, 7, 0.29%
Pleiades Publishing
7 publications, 0.29%
American Scientific Publishers
American Scientific Publishers, 7, 0.29%
American Scientific Publishers
7 publications, 0.29%
KeAi Communications Co.
KeAi Communications Co., 7, 0.29%
KeAi Communications Co.
7 publications, 0.29%
Oxford University Press
Oxford University Press, 7, 0.29%
Oxford University Press
7 publications, 0.29%
Institution of Engineering and Technology (IET)
Institution of Engineering and Technology (IET), 6, 0.25%
Institution of Engineering and Technology (IET)
6 publications, 0.25%
Beilstein-Institut
Beilstein-Institut, 5, 0.2%
Beilstein-Institut
5 publications, 0.2%
Spandidos Publications
Spandidos Publications, 5, 0.2%
Spandidos Publications
5 publications, 0.2%
World Scientific
World Scientific, 5, 0.2%
World Scientific
5 publications, 0.2%
American Association for the Advancement of Science (AAAS)
American Association for the Advancement of Science (AAAS), 5, 0.2%
American Association for the Advancement of Science (AAAS)
5 publications, 0.2%
Walter de Gruyter
Walter de Gruyter, 5, 0.2%
Walter de Gruyter
5 publications, 0.2%
Shenyang Pharmaceutical University, 4, 0.16%
Shenyang Pharmaceutical University
4 publications, 0.16%
American Association for Cancer Research (AACR)
American Association for Cancer Research (AACR), 4, 0.16%
American Association for Cancer Research (AACR)
4 publications, 0.16%
100
200
300
400
500
600
700
800
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Danhier F. et al. PLGA-based nanoparticles: An overview of biomedical applications // Journal of Controlled Release. 2012. Vol. 161. No. 2. pp. 505-522.
GOST all authors (up to 50) Copy
Danhier F., Ansorena E., Silva J. G., Coco R., Le Breton A., Pr ?? at V. PLGA-based nanoparticles: An overview of biomedical applications // Journal of Controlled Release. 2012. Vol. 161. No. 2. pp. 505-522.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.jconrel.2012.01.043
UR - https://doi.org/10.1016%2Fj.jconrel.2012.01.043
TI - PLGA-based nanoparticles: An overview of biomedical applications
T2 - Journal of Controlled Release
AU - Danhier, Fabienne
AU - Ansorena, Eduardo
AU - Silva, Joana G.
AU - Coco, Régis
AU - Le Breton, Aude
AU - Pr ?? at, V??ronique
PY - 2012
DA - 2012/07/01 00:00:00
PB - Elsevier
SP - 505-522
IS - 2
VL - 161
SN - 0168-3659
SN - 1873-4995
ER -
BibTex |
Cite this
BibTex Copy
@article{2012_Danhier,
author = {Fabienne Danhier and Eduardo Ansorena and Joana G. Silva and Régis Coco and Aude Le Breton and V??ronique Pr ?? at},
title = {PLGA-based nanoparticles: An overview of biomedical applications},
journal = {Journal of Controlled Release},
year = {2012},
volume = {161},
publisher = {Elsevier},
month = {jul},
url = {https://doi.org/10.1016%2Fj.jconrel.2012.01.043},
number = {2},
pages = {505--522},
doi = {10.1016/j.jconrel.2012.01.043}
}
MLA
Cite this
MLA Copy
Danhier, Fabienne, et al. “PLGA-based nanoparticles: An overview of biomedical applications.” Journal of Controlled Release, vol. 161, no. 2, Jul. 2012, pp. 505-522. https://doi.org/10.1016%2Fj.jconrel.2012.01.043.
Found error?